Advancy served as strategic vendor due diligence (VDD) advisor to EagleTree Capital on its definitive agreement to sell gChem to ContextLogic Holdings Inc. at an enterprise value of $850 million.

A Global Leader in Specialty Chemicals

gChem is the world’s leading manufacturer and technologist of dimethyl sulfoxide (DMSO) and non-toxic ingredients. Its products serve critical markets such as healthcare, agriculture, semiconductors, and aerospace.

Under EagleTree Capital’s ownership, gChem strengthened its core strategic assets:

• Industrial Autonomy: Achieved full vertical integration and secured key input supply at its state-of-the-art facility in Tuscaloosa, Alabama.

• Innovation & Compliance: Expanded its portfolio of non-toxic solvent alternatives, including its flagship Procipient line (the only health-grade certified DMSO).

Transaction Structure & Next Steps

Advancy supported EagleTree Capital by delivering the strategic vendor due diligence for the transaction. The deal is expected to close in the fourth quarter of 2026, subject to customary regulatory approvals.

Following completion, gChem will operate as ContextLogic’s second business platform, maintaining its headquarters in Covington, Louisiana, under the leadership of CEO Frank Roederer and the current executive team.

Congratulations to the teams at EagleTree Capital, gChem, and ContextLogic on this milestone deal.

Discover Advancy’s M&A & Strategy Expertise